Features Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity? News Moderna eyes combined Covid-19, flu booster by 2023
Features Timing of Synairgen Phase III nebulised Covid-19 treatment remains a challenge Adam Zamecnik
Features Vaxart oral Covid-19 vaccine: could trial execution obstacles delay market entry? Reynald Castañeda
Comment Vaccination in children aged 5–11 years will likely cut Covid-19 mortality in the US GlobalData Healthcare
Features Vaxine to file for Australian approval of protein subunit Covid-19 vaccine Reynald Castañeda
Features Can DreamTec turn its bacteria-based oral Covid-19 vaccine into a reality? Reynald Castañeda